Eli Lilly and Novo Nordisk to maintain 'two-horse race' in GLP-1 weight loss market
U.Ozel.Images/E+ via Getty Images Although other companies are on the cusp of gaining approval for GLP-1 receptor agonist weight-loss drugs, ...
U.Ozel.Images/E+ via Getty Images Although other companies are on the cusp of gaining approval for GLP-1 receptor agonist weight-loss drugs, ...